Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

NCT06593392 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Pruritus
Chronic Kidney Diseases

Interventions

DRUG: Difelikefalin

Sponsor

Vifor Fresenius Medical Care Renal Pharma